LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT)

Ting Peng & Peng Wu et al. · 2022-05-11

Lysyl oxidase-like 2 (